<VariationArchive RecordType="classified" VariationID="522950" VariationName="NM_020812.4(DOCK6):c.4824_4828del (p.Glu1609fs)" VariationType="Deletion" Accession="VCV000522950" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2018-04-29" MostRecentSubmission="2022-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="513656" VariationID="522950">
      <GeneList>
        <Gene Symbol="DOCK6" FullName="dedicator of cytokinesis 6" GeneID="57572" HGNC_ID="HGNC:19189" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11199295" stop="11262524" display_start="11199295" display_stop="11262524" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11309968" stop="11373167" display_start="11309968" display_stop="11373167" Strand="-" />
          </Location>
          <OMIM>614194</OMIM>
        </Gene>
        <Gene Symbol="DOCK6-AS1" FullName="DOCK6 antisense RNA 1" GeneID="105372273" HGNC_ID="HGNC:56684" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11203628" stop="11221573" display_start="11203628" display_stop="11221573" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_020812.4(DOCK6):c.4824_4828del (p.Glu1609fs)</Name>
      <CanonicalSPDI>NC_000019.10:11209026:GCTCCGC:GC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11209027" stop="11209031" display_start="11209027" display_stop="11209031" variantLength="5" positionVCF="11209026" referenceAlleleVCF="AGCTCC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11319703" stop="11319707" display_start="11319703" display_stop="11319707" variantLength="5" positionVCF="11319702" referenceAlleleVCF="AGCTCC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>E1609fs</ProteinChange>
      <ProteinChange>E1644fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.11209029_11209033del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.11209029_11209033del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.11319705_11319709del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.11319705_11319709del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031953.1" sequenceAccession="NG_031953" sequenceVersion="1" change="g.58462_58466del">
            <Expression>NG_031953.1:g.58462_58466del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367830.1" sequenceAccession="NM_001367830" sequenceVersion="1" change="c.4929_4933del">
            <Expression>NM_001367830.1:c.4929_4933del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354759.1" sequenceAccession="NP_001354759" sequenceVersion="1" change="p.Glu1644fs">
            <Expression>NP_001354759.1:p.Glu1644fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020812.4" sequenceAccession="NM_020812" sequenceVersion="4" change="c.4824_4828del" MANESelect="true">
            <Expression>NM_020812.4:c.4824_4828del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065863.2" sequenceAccession="NP_065863" sequenceVersion="2" change="p.Glu1609fs">
            <Expression>NP_065863.2:p.Glu1609fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799168" DB="ClinGen" />
        <XRef Type="rs" ID="1555826472" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020812.4(DOCK6):c.4824_4828del (p.Glu1609fs) AND Adams-Oliver syndrome 2" Accession="RCV000626147" Version="4">
        <ClassifiedConditionList TraitSetID="7604">
          <ClassifiedCondition DB="MedGen" ID="C3280182">Adams-Oliver syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-12-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-04-29" MostRecentSubmission="2022-12-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7604" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16531" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adams-Oliver syndrome 2</ElementValue>
                <XRef ID="Adams-Oliver+syndrome+2/7632" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013635" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOS2</ElementValue>
                <XRef Type="MIM" ID="614219" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15775" />
                <XRef ID="15775" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Adams-Oliver syndrome (AOS) is characterized by aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD). ACC lesions usually occur in the midline of the parietal or occipital regions, but can also occur on the abdomen or limbs. At birth, an ACC lesion may already have the appearance of a healed scar. ACC lesions less than 5 cm often involve only the skin and almost always heal over a period of months; larger lesions are more likely to involve the skull and possibly the dura, and are at greater risk for complications, which can include infection, hemorrhage, or thrombosis, and can result in death. The limb defects range from mild (unilateral or bilateral short distal phalanges) to severe (complete absence of all toes or fingers, feet or hands, or more, often resembling an amputation). The lower extremities are almost always more severely affected than the upper extremities. Additional major features frequently include cardiovascular malformations/dysfunction (23%), brain anomalies, and less frequently renal, liver, and eye anomalies.</Attribute>
                <XRef ID="NBK355754" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27077170</ID>
                <ID Source="BookShelf">NBK355754</ID>
              </Citation>
              <XRef ID="974" DB="Orphanet" />
              <XRef ID="C3280182" DB="MedGen" />
              <XRef ID="MONDO:0013635" DB="MONDO" />
              <XRef Type="MIM" ID="614219" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1454135" SubmissionDate="2017-12-18" DateLastUpdated="2022-12-11" DateCreated="2018-04-29">
        <ClinVarSubmissionID localKey="NM_020812.3:c.4824_4828del|MedGen:C3280182" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000746779" DateUpdated="2022-12-11" DateCreated="2018-04-29" Type="SCV" Version="2" SubmitterName="Genomic Research Center, Shahid Beheshti University of Medical Sciences" OrgID="504864" OrganizationCategory="laboratory" OrgAbbreviation="GRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <GeographicOrigin>Iran</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020812.3:c.4824_4828del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280182" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES Dec 2017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1454135" TraitType="Disease" MappingType="XRef" MappingValue="C3280182" MappingRef="MedGen">
        <MedGen CUI="C3280182" Name="Adams-Oliver syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

